Arsenic Trioxide

Acytostatics, Aresenic Trioxide’s active ingredient leads to a fragmentation of the DNA, which then leads to apoptosis (cell death). It is predominantly used in the treatment of a subtype of blood cancer (APL).

Formula: As2O3

Molecular weight: 0.00 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Antineoplastic drugs

Status: Commercial

Axano Pharmaceuticals Ltd
contact us now